[Medical treatment of juvenile hemangiomas]

Autor:	L-M, Boon, A-C, Bataille, V, Bernier, C, Vermylen, G, Verellen
Jazyk:	francouzština
Rok vydání:	2006
Předmět:	Skin Neoplasms Adrenal Cortex Hormones Vincristine Humans Infant Interferon-alpha Angiogenesis Inhibitors Antineoplastic Agents Hemangioma Capillary Laser Therapy Interferon alpha-2 Antineoplastic Agents Phytogenic Recombinant Proteins
Zdroj:	Annales de chirurgie plastique et esthetique. 51(4-5)
ISSN:	0294-1260
Popis:	Infantile hemangioma always involute in 5 to 7 years. However, 10% of proliferating hemangiomas will necessitate a therapeutic approach, often medical, in order to avoid life or organ threatening, fonctional or esthetic sequelae. "Which hemangioma need to be treated, when and how" are important questions for the optimal management of infantile hemangiomas. Corticotherapy is still the treatment of choice for these lesions. Other anti-angiogenic molecules have also been successfully used such as interferon alfa-2a and vincristine. This chapter tries to answer these questions and detail the different medical modalities for the treatment of infantile hemangioma.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::139c6d6318229762ec8486429772c2e4 https://pubmed.ncbi.nlm.nih.gov/16997446 Zobrazit plný text záznamu Full Text from ScienceDirect